Literature DB >> 20310007

ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation.

Susanne A Schneider1, Coro Paisan-Ruiz, Niall P Quinn, Andrew J Lees, Henry Houlden, John Hardy, Kailash P Bhatia.   

Abstract

Kufor Rakeb disease (KRD, PARK9) is an autosomal recessive extrapyramidal-pyramidal syndrome with generalized brain atrophy due to ATP13A2 gene mutations. We report clinical details and investigational results focusing on radiological findings of a genetically-proven KRD case. Clinically, there was early onset levodopa-responsive dystonia-parkinsonism with pyramidal signs and eye movement abnormalities. Brain MRI revealed generalized atrophy and putaminal and caudate iron accumulation bilaterally. Our findings add KRD to the group of syndromes of neurodegeneration with brain iron accumulation (NBIA). KRD should be considered in patients with dystonia-parkinsonism with iron on brain imaging and we suggest classifying as NBIA type 3. (c) 2010 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20310007     DOI: 10.1002/mds.22947

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  53 in total

Review 1.  Genetics of neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

Review 2.  The neuropathology of neurodegeneration with brain iron accumulation.

Authors:  Michael C Kruer
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

3.  Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein.

Authors:  Jieqiong Tan; Tongmei Zhang; Li Jiang; Jingwei Chi; Dongshen Hu; Qian Pan; Danling Wang; Zhuohua Zhang
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

Review 4.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

5.  Different cortical excitability profiles in hereditary brain iron and copper accumulation.

Authors:  Raffaele Dubbioso; Lucia Ruggiero; Marcello Esposito; Paola Tarantino; Marcello De Angelis; Francesco Aruta; Sabina Pappatà; Lorenzo Ugga; Alberto Piperno; Raffaele Iorio; Lucio Santoro; Rosa Iodice; Fiore Manganelli
Journal:  Neurol Sci       Date:  2019-11-26       Impact factor: 3.307

Review 6.  Parkinson's disease and iron.

Authors:  Hideki Mochizuki; Chi-Jing Choong; Kousuke Baba
Journal:  J Neural Transm (Vienna)       Date:  2020-02-05       Impact factor: 3.575

Review 7.  Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.

Authors:  Susanne A Schneider; Roy N Alcalay
Journal:  Mov Disord       Date:  2017-11       Impact factor: 10.338

Review 8.  Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.

Authors:  Ming Guo
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

9.  Shadows of an absent partner: ATP hydrolysis and phosphoenzyme turnover of the Spf1 (sensitivity to Pichia farinosa killer toxin) P5-ATPase.

Authors:  Gerardo R Corradi; Felicitas de Tezanos Pinto; Luciana R Mazzitelli; Hugo P Adamo
Journal:  J Biol Chem       Date:  2012-06-28       Impact factor: 5.157

Review 10.  Neurodegeneration with Brain Iron Accumulation.

Authors:  Susanne A Schneider
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.